Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: a case report and review of the literature

被引:39
作者
Simmons, JH
Zeitler, PS
Fenton, LZ
Abzug, MJ
Fiallo-Scharer, RV
Klingensmith, GJ
机构
[1] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA
[2] Childrens Hosp, Dept Pediat, Div Radiol, Denver, CO 80218 USA
[3] Childrens Hosp, Dept Pediat, Div Infect Dis, Denver, CO 80218 USA
关键词
mucormycosis; pediatric; rhinocerebral; type; 1; diabetes;
D O I
10.1111/j.1399-543X.2005.00118.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To illustrate that rapid diagnosis and aggressive treatment of rhinocerebral mucormycosis with internal carotid artery occlusion in a pediatric patient can prevent mortality and significant morbidity. Research Designs and Methods: Rhinocerebral mucormycosis infrequently occurs in the pediatric population, and when it involves thrombosis of an internal carotid artery, it has been almost uniformly fatal. We present an 8-yr-old girl with type 1 diabetes mellitus who has survived such an infection for 2 yr, and who has minimal residual morbidity. We believe she is the youngest patient to survive rhinocerebral mucormycosis complicated by internal carotid artery and cavernous sinus thromboses. She has survived with an intensive regimen including aggressive surgical debridement, amphotericin B, rigorous glucose control, hyperbaric oxygen therapy, interferon-gamma, posaconazole (an experimental antifungal), and granulocyte-macrophage colony-stimulating factor. Conclusions: This article illustrates the importance of prompt recognition and aggressive treatment of fungal infection in patients with diabetes. Additionally, it emphasizes that such treatment can have an excellent outcome, and mortality and significant morbidity can be avoided. Finally, we provide a review of the literature regarding mucormycosis infections and treatment options.
引用
收藏
页码:234 / 238
页数:5
相关论文
共 23 条
  • [1] Long-term survival of a patient with invasive cranial base rhinocerebral mucormycosis treated with combined endovascular, surgical, and medical therapies: Case report
    Alleyne, CH
    Vishteh, AG
    Spetzler, RF
    Detwiler, PW
    [J]. NEUROSURGERY, 1999, 45 (06) : 1461 - 1463
  • [2] BLITZER A, 1980, LARYNGOSCOPE, V90, P635, DOI 10.1288/00005537-198004000-00010
  • [3] COUCH L, 1988, ARCH OTOLARYNGOL, V114, P791
  • [4] FERGUSON BJ, 1988, REV INFECT DIS, V10, P551
  • [5] Preface - Fungal infections, - Part I - Recent advances in diagnosis, treatment, and prevention of opportunistic mycoses
    Walsh, TJ
    Rex, JH
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2002, 16 (04) : IX - X
  • [6] Disseminated zygomycosis in a neutropenic patient: Successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor
    Gonzalez, CE
    Couriel, DR
    Walsh, TJ
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) : 192 - 196
  • [7] Diabetes mellitus, fever, proptosis, and rapid loss of vision
    Goswami, R
    Tandon, N
    Thulkar, S
    Kochupillai, N
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1996, 72 (852) : 633 - 635
  • [8] Management of CNS mucormycosis in the pediatric patient
    Hamilton, JF
    Bartkowski, HB
    Rock, JP
    [J]. PEDIATRIC NEUROSURGERY, 2003, 38 (04) : 212 - 215
  • [9] HARRIS JS, 1955, PEDIATRICS, V16, P857
  • [10] LOWE JT, 1975, ARCH OTOLARYNGOL, V101, P100